Food for Special Medical Purposes (FSMP)

Specially processed or formulated foods intended for the dietary management of patients, subject to specific composition, labeling, and notification requirements under dedicated frameworks.

Foresight tracks Food for Special Medical Purposes (FSMP) developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.

Not ready for a trial? Take the 3-minute readiness assessment

Current activity

Steady

In line with the prior 8-week baseline

3-month trend

Latest alerts below

Last updated

22 April 2026, 16:48

View alerts

Latest Food for Special Medical Purposes (FSMP) developments

Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.

France DGCCRF Inspects Foods For Special Medical Purposes; Finds Nutrition Labelling Irregularities

France’s DGCCRF has published 2023 enforcement results for 47 establishments manufacturing or selling foods for special medical purposes, revealing widespread online-commerce breaches and inaccurate nutrition labelling, with one product deemed unfit for consumption. This signals heightened scrutiny of FSMP formulations, origin claims and digital product information in France, so companies should tighten controls on labelling, notification obligations and e-commerce practices to avoid sanctions.

economie.gouv.frFranceFrance

EU Commission Proposes Amendments to Maximum Levels of 3‑MCPD and Glycidyl Esters in Certain Foods

The European Commission has proposed stricter maximum levels for 3-MCPD and glycidyl esters in baby foods and vegetable oils, with a planned application date of January 1, 2027. Food manufacturers and oil refiners must prepare for tighter analytical compliance and potential reformulation to meet new safety thresholds for sensitive consumer categories.

docs.wto.orgEuropean UnionEuropean Union

China SAMR Orders Half-Year Cleanup of Prompt Language in Advertising

China has initiated a six-month nationwide enforcement campaign targeting misleading advertising disclosures and inadequate risk warnings for complex and regulated products. Businesses should prioritize auditing marketing materials to ensure statutory warnings and limiting conditions are prominent and substantiated to avoid significant administrative penalties.

samr.gov.cnChinaChina

UK Department of Health and Social Care Updates ACBS Application Guidance and Submission Deadlines

The UK has updated submission deadlines and transitioned to a digital-only application process for the Advisory Committee on Borderline Substances through 2027. Manufacturers of specialized medical foods and supplements must align product development and reimbursement strategies with these fixed windows to ensure uninterrupted NHS market access.

gov.ukUnited KingdomUnited Kingdom

China CFSA Consults on Four New Food Additives Including Two HMOs

China is advancing the authorization of four new food additives and nutrition enhancers following successful technical safety reviews for use in infant formula and food processing. This move signals an imminent update to national food safety standards that will expand market access for specialized ingredients and align domestic requirements with international benchmarks.

cfsa.net.cnChinaChina

Japan CAA Grants Labelling Permission for One Food for Special Dietary Uses

Japan's Consumer Affairs Agency has authorized a new product for special dietary use labeling, effective March 2026. This action underscores the rigorous pre-market approval requirements for health-related claims, necessitating individual product clearance before targeting specific medical or demographic segments.

caa.go.jpJapanJapan

Poland Publishes Monitoring Report for WHO Programme on Elimination of Industrial Trans Fats in Food

Poland has published a monitoring report confirming successful elimination of industrial trans fats in alignment with WHO validation and EU limits. Businesses should expect continued rigorous market surveillance and data reporting ahead of a 2026 WHO re-evaluation.

pzh.gov.plPolandPoland

Belgium AFSCA Sets Action Limits for Cereulide in Infant and Young Child Food

Belgium has established mandatory action limits for cereulide in infant and young child food products to address acute toxicity risks. Exceeding these thresholds triggers immediate market withdrawals and recalls, necessitating enhanced batch testing and rigorous supply chain verification for sensitive ingredients.

favv-afsca.beBelgiumBelgium

EU Commission Implementing Regulation (EU) 2026/386 Authorises Defatted Rapeseed Powder as a Novel Food

The EU has authorized defatted rapeseed powder as a novel food for broad use in food and supplements starting March 2026. Market entry requires strict adherence to allergen labeling for mustard sensitivity and navigation of a five-year exclusivity period for the primary applicant.

eur-lex.europa.euEuropean UnionEuropean Union

Commission Implementing Regulation (EU) 2026/397 Authorising Lacto‑N‑Tetraose Produced by Derivative E. coli K‑12 MG1655 as a Novel Food

The European Commission has authorized Lacto-N-tetraose produced by a specific genetically modified strain as a novel food starting March 2026. This approval enables the use of this human milk oligosaccharide in infant formula and supplements while granting the applicant five years of market exclusivity.

eur-lex.europa.euEuropean UnionEuropean Union

Korea MFDS Publishes Draft Amendment To Standards And Specifications For Food Additives (Notice 2026-084)

South Korea proposed a draft amendment in February 2026 to liberalize food additive standards for nutrient fortifiers and sulphites while aligning phosphate classifications with international norms. This shift offers greater formulation flexibility for health and medical foods but introduces new safety-driven usage limits for polyol sweeteners that may necessitate recipe or labeling updates.

mfds.go.krSouth KoreaSouth Korea

EFSA Rapid Risk Assessment Derives ARfD for Cereulide in Infants

EFSA has established a new acute reference dose for cereulide in infants, setting strict safety thresholds for infant and follow-on formulae. Manufacturers should anticipate harmonized EU-wide risk management and potential new concentration limits to ensure compliance with these updated safety benchmarks.

efsa.europa.euEuropean UnionEuropean Union

Mexico Draft Standard PROY-NOM-072-SSA1-2025 On Labelling of Medicines and Herbal Remedies

Mexico has proposed updated mandatory labeling requirements for medicines and herbal remedies, introducing stricter rules for warnings, QR code integration, and Braille accessibility. Companies must prepare for significant packaging revisions and digital leaflet adoption to maintain compliance with COFEPRIS sanitary regulations and ensure market access.

dof.gob.mxMexicoMexico

Mexico Draft PROY-NOM-249-SSA1-2025: Requirements for Sterile Compounding and Preparation Facilities

Mexico has proposed updated sanitary and quality standards for facilities preparing sterile nutritional and medicinal admixtures, with consultations closing in March 2026. Healthcare operators must align infrastructure and quality management systems with international cleanroom and pharmaceutical standards to ensure product integrity and patient safety.

dof.gob.mxMexicoMexico

EU Amends Food Additives Regulation for Gums, Pectins and Starch Sodium Octenyl Succinate

The EU has updated use conditions and purity specifications for several food additive gums and pectins, with new requirements for infant and young children's products taking effect from August 2026. Manufacturers must tighten supply chain controls for heavy metals and microbiological purity while reviewing formulations to comply with reduced maximum levels and new combined-use restrictions.

eur-lex.europa.euEuropean UnionEuropean Union

Japan Consumer Affairs Agency Grants Labelling Permission For Three Foods For Special Dietary Uses

Japan's Consumer Affairs Agency has granted mandatory labeling permissions for three new products under the Foods for Special Dietary Uses category. This action reinforces the strict pre-market approval regime for specialized nutritional claims, requiring manufacturers to secure individual authorizations before targeting specific demographic or medical groups.

caa.go.jpJapanJapan

Germany Publishes Recall Notice For BEBA And ALFAMINO Infant Formula Over Cereulide Toxin Risk

German authorities have initiated a nationwide recall of specific infant formula batches due to potential cereulide toxin contamination. This enforcement action highlights the critical importance of microbial toxin screening and supplier oversight for maintaining market access in the highly regulated nutrition sector.

lebensmittelwarnung.deGermanyGermany

Germany (BVL) Modernises Online Notification Procedures For Food Supplements And Foods For Specific Consumer Groups

Germany is transitioning all food supplement and specialized food notifications to a mandatory online-only portal by July 2026. Businesses must adapt digital compliance infrastructure to meet new federal standards and prevent disruptions to product marketability.

bvl.bund.deGermanyGermany

EFSA Updates Administrative Guidance for New Nutrient Source Dossiers (2025/2026)

EFSA has updated administrative guidance for nutrient source applications with phased implementation starting November 2025 and January 2026. Companies must align dossier submissions with new transparency and data standards to ensure continued market access for food supplements and fortified products.

efsa.onlinelibrary.wiley.comEuropean UnionEuropean Union

CJEU Clarifies Labelling Rules for Special Medical Purpose Foods

The CJEU has ruled that repeating mandatory nutrition information on the front of packaging for special medical purpose foods is prohibited under EU law. Manufacturers must audit packaging layouts to ensure nutrition data is not duplicated, as the Court has strictly limited additional labeling particulars for these specialized products.

eur-lex.europa.euEuropean UnionEuropean Union

Not a newsletter. Not a feed. Structured intelligence mapped to your business.

These are just a few of the most recent Food for Special Medical Purposes (FSMP) alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.

Start free trial

Topic context

How to read Food for Special Medical Purposes (FSMP) regulatory activity

Definition

What is Food for Special Medical Purposes (FSMP)?

Specially processed or formulated foods intended for the dietary management of patients, subject to specific composition, labeling, and notification requirements under dedicated frameworks.

Industry relevance

Why it matters

Food for Special Medical Purposes (FSMP) developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.

Foresight tracking

How Foresight monitors it

Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.

Frequently asked questions

Everything you need to know about Foresight's regulatory intelligence platform

Still have questions? Get in touch with our team

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX